The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution.
Open accessAbstract
High-density lipoprotein (HDL) cholesterol (HDL-C) levels are a strong inverse predictor of atherosclerosis risk, but the physiological determinants of HDL-C levels are poorly understood. We selected 57 human subjects (30 women and 27 men) with a broad range of HDL-C levels and performed turnover studies of apolipoprotein (apo)A-I and apoA-II, the two major apolipoproteins of HDL, to measure the fractional catabolic rate (FCR) and production or transport rate (TR) of these proteins. We also measured several other parameters known to correlate with HDL-C levels to test for their interrelations and to postulate mechanisms of regulation of HDL-C levels. As expected, the women had higher levels of HDL-C (56.7 +/- 21.4 versus 45.1 +/- 16.3 mg/dL, mean +/- SD; P = .03) and apoA-I (147 +/- 32 versus 126 +/- 29 mg/dL, P = .01) than men and did not differ in apoA-II levels (34.5 +/- 7.4 versus 33.3 +/- 7.5 mg/dL, P > .2). The FCR of apoA-I tended to be lower in the women (0.248 +/- 0.077 versus 0.277 +/- 0.069 pools/d, P = .1), although the difference was not statistically significant. The FCR of apoA-II was also lower (0.184 +/- 0.043 versus 0.216 +/- 0.056 pools/d, P = .02). In contrast, the apoA-I TR was equal in women and men (12.0 +/- 1.6 versus 12.1 +/- 2.8 mg/kg per day, P > .2), and there was a trend toward lower apoA-II TR in women (2.19 +/- .62 versus 2.61 +/- 1.06 mg/kg per day, P = .07). Linear regression analysis revealed a strong inverse correlation between HDL-C levels and the FCRs of apoA-I and apoA-II (r = -.81 and -.76, respectively; P < .0001 for both). In contrast, there was little or no association between HDL-C and the TRs of apoA-I and apoA-II (r = .06 and -.35, P = not significant and .01, respectively). In stepwise multiple linear regression analysis, apoA-I FCR alone accounted for 66% of the variability in HDL-C; two other variables accounted for an additional 7%. Due to the importance of apoA-I FCR, its determinants were sought among the remaining variables.(ABSTRACT TRUNCATED AT 400 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Small HDL in hypertriglyceridemia is associated with hypercatabolism of apolipoprotein A-I (47, 48), and it seems to be related to elevated hepatic lipase activity in central obesity and insulin resistance (49).”
From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [48]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These data suggest that catabolism rather than production is the major determinant of HDL apoA-I levels, as suggested by previous studies (43)(44)(45).”
From Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans (2003) · cites this paper as [45]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Miller, G. J., & Miller, N. E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92376-4 · Cited by 2,621
A biometric study of basal metabolism in man
Harris, J. A., & Benedict, F. G. (2014) · Medical Entomology and Zoology · Cited by 1,847
Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease.
Després, J. P., Moorjani, S., Lupien, P. J., Tremblay, A., Nadeau, A., & Bouchard, C. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.4.497 · Cited by 1,248
High density lipoprotein metabolism.
Eisenberg, S. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37713-0 · Cited by 1,212
Self-citationThe Theory of Tracer Experiments with 131I-Labelled Plasma Proteins
Matthews, C. M. E. (1957) · Physics in Medicine and Biology · doi:10.1088/0031-9155/2/1/305 · Cited by 831
The Measurement of Apolipoprotein A-I and A-II Levels in Men and Women by Immunoassay
Cheung, M. C., & Albers, J. J. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108767 · Cited by 381
The Effects of Estrogen Administration on Plasma Lipoprotein Metabolism in Premenopausal Females
Schaefer, E. J., Foster, D. M., Zech, L. A., Lindgren, F. T., Brewer, H. B., & Levy, R. I. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-262 · Cited by 337
Insulin stimulation of adipose tissue lipoprotein lipase. Use of the euglycemic clamp technique.
Sadur, C. N., & Eckel, R. H. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110547 · Cited by 288
Grundy, S. M., Mok, H. Y. I., Zech, L. A., Steinberg, D. H., & Berman, M. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109422 · Cited by 283
Brinton, E. A., Eisenberg, S., & Breslow, J. L. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114405 · Cited by 258
Self-citation
Research works printed but not linked: 3
- Miller NE. High density lipoprotein as a predictor of clinical coronary heart disease. In: Fidge NH, Nestel PJ, eds. Athero- sclerosis VII. Amsterdam, the Netherlands: Elsevier; 1986:61.
- National Health and Nutrition Examination Survey. Dietary intake source data, 11. Hyattsville, Md: National Center for Health Statistics; Office of Health Research Statistics and Technology; 1983:48-52.
- Sadur CN, Eckel RH. Insulin stimulation of adipose tissue lipo- protein lipase. J Clin Invest. 1982;69:1119-1125.
Cited by
Sorted by citations
New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport
Lewis, G. F., & Rader, D. J. (2005) · Circulation Research · doi:10.1161/01.res.0000170946.56981.5c · Cited by 1,104
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., Sacks, F., Murad, M. H., & Stalenhoef, A. F. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3213 · Cited by 887
“Small HDL in hypertriglyceridemia is associated with hypercatabolism of apolipoprotein A-I (47, 48), and it seems to be related to elevated hepatic lipase activity in central obesity and insulin resistance (49).”
InfluentialAndrogens and Coronary Artery Disease
Wu, F. C. W., & von Eckardstein, A. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0025 · Cited by 596
Nicotinic acid: the broad‐spectrum lipid drug. A 50th anniversary review
Carlson, L. A. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01528.x · Cited by 591
The metabolic syndrome: is this diagnosis necessary?1,2
Reaven, G. M. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1237 · Cited by 523
Rosenson, R. S., Brewer, H. B., Chapman, M. J., Fazio, S., Hussain, M. M., Kontush, A., Krauss, R. M., Otvos, J. D., Remaley, A. T., & Schaefer, E. J. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.155333 · Cited by 523
Dyslipidemia and inflammation: an evolutionary conserved mechanism
Esteve, E., Ricart, W., & Fernández-Real, J. M. (2005) · Clinical Nutrition · doi:10.1016/j.clnu.2004.08.004 · Cited by 492
Soppert, J., Lehrke, M., Marx, N., Jankowski, J., & Noels, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.019 · Cited by 440
Silva, E. R. D. O. E., Foster, D., Harper, M. M., Seidman, C. E., Smith, J. D., Breslow, J. L., & Brinton, E. A. (2000) · Circulation · doi:10.1161/01.cir.102.19.2347 · Cited by 319
Self-citationGlycation impairs high-density lipoprotein function
Hedrick, C. C., Thorpe, S. R., Fu, M.-X., Harper, C. M., Yoo, J. H., Kim, S.-M., Wong, H., & Peters, A. L. (2000) · Diabetologia · doi:10.1007/s001250050049 · Cited by 310
Weinstock, P. H., Bisgaier, C. L., Aalto-Setälä, K., Radner, H., Ramakrishnan, R., Levak-Frank, S., Essenburg, A. D., Zechner, R., & Breslow, J. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118319 · Cited by 254
Self-citationTargeting inflammation in metabolic syndrome
Welty, F. K., Alfaddagh, A., & Elajami, T. K. (2016) · Translational Research · doi:10.1016/j.trsl.2015.06.017 · Cited by 287
Attie, A., Kastelein, J. J. P., & Hayden, M. R. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31498-x · Cited by 286
Rashid, S., Watanabe, T., Sakaue, T., & Lewis, G. F. (2003) · Clinical Biochemistry · doi:10.1016/s0009-9120(03)00078-x · Cited by 277
Pathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review
Bjornstad, P., & Eckel, R. H. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1101-6 · Cited by 262
Vaisman, B. L., Lambert, G. C., Amar, M. J., Joyce, C. W., Ito, T., Shamburek, R. D., Cain, W. J., Fruchart‐Najib, J., Neufeld, E. D., Remaley, A. T., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12517 · Cited by 240
Insulin Resistance in Obesity as the Underlying Cause for the Metabolic Syndrome
Gallagher, E. J., LeRoith, D., & Karnieli, E. (2010) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20212 · Cited by 244
Insulin resistance and coronary heart disease in nondiabetic individuals
Reaven, G. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.241885 · Cited by 227
Brousseau, M. E., Diffenderfer, M. R., Millar, J. S., Nartsupha, C., Asztalos, B. F., Welty, F. K., Wolfe, M. L., Rudling, M. J., Björkhem, I., Angelin, B., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000161928.16334.dd · Cited by 230
Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men
Lamarche, B., Uffelman, K. D., Carpentier, A. C., Cohn, J. S., Steiner, G., Barrett, P. H. R., & Lewis, G. F. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5286 · Cited by 230
Gotto, A. M., & Brinton, E. A. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.08.061 · Cited by 233
Self-citationHow Do Elevated Triglycerides and Low HDL-Cholesterol Affect Inflammation and Atherothrombosis?
Welty, F. K. (2013) · Current Cardiology Reports · doi:10.1007/s11886-013-0400-4 · Cited by 221
Watts, G. F., Barrett, P. H. R., Ji, J., Serone, A. P., Chan, D. C., Croft, K. D., Loehrer, F., & Johnson, A. G. (2003) · Diabetes · doi:10.2337/diabetes.52.3.803 · Cited by 219
Pascot, A., Lemieux, I., Prud’homme, D., Tremblay, A., Nadeau, A., Couillard, C., Bergeron, J., Lamarche, B., & Després, J. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31529-7 · Cited by 186
HDL metabolism in hypertriglyceridemic states: an overview
Lamarche, B., Rashid, S., & Lewis, G. F. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00098-4 · Cited by 184
Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels
Marcovina, S. M., & Packard, C. J. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01648.x · Cited by 180
Liadaki, K. N., Liu, T., Xu, S., Ishida, B. Y., Duchateaux, P. N., Krieger, J. P., Kane, J. P., Krieger, M., & Zannis, V. I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002310200 · Cited by 162
Mekki, N., Christofilis, M., Charbonnier, M., Atlan-Gepner, C., Defoort, C., Juhel, C., Borel, P., Portugal, H., Pauli, A.-M., Vialettes, B., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5397 · Cited by 173
Faergeman, O., Holme, I., Fayyad, R., Bhatia, S., Grundy, S. M., Kastelein, J. J. P., LaRosa, J. C., Larsen, M. L., Lindahl, C., Olsson, A. G., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.04.008 · Cited by 154
Hoehner, C. M., Greenlund, K. J., Rith-Najarian, S., Casper, M. L., & McClellan, W. M. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000015762.92814.85 · Cited by 150
The insulin resistance syndrome and postprandial lipid intolerance in smokers
Eliasson, B., Mero, N., Taskinen, M., & Smith, U. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06028-5 · Cited by 149
Apolipoprotein A-II, HDL metabolism and atherosclerosis
Tailleux, A., Duriez, P., Fruchart, J., & Barthelemy-Clavey, V. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00751-1 · Cited by 148
Weng, W., & Breslow, J. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14788 · Cited by 148
Self-citationBülow, B., Hagmar, L., ESKILSSON, J., & Erfurth, E. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6346 · Cited by 144
The impact of aerobic exercise on HDL quantity and quality: a narrative review
Franczyk, B., Gluba-Brzózka, A., Ciałkowska-Rysz, A., Ławiński, J., & Rysz, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054653 · Cited by 142
Reaven, G. M. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.12.001 · Cited by 146
Calabresi, L., Villa, B., Canavesi, M., Sirtori, C. R., James, R. W., Bernini, F., & Franceschini, G. (2004) · Metabolism · doi:10.1016/j.metabol.2003.09.007 · Cited by 132
Jeong, T., Schissel, S. L., Tabas, I. A., Pownall, H. J., Tall, A. R., & Jiang, X. (1998) · Journal of Clinical Investigation · doi:10.1172/jci870 · Cited by 133
GENETICS OF LIPOPROTEIN ABNORMALITIES ASSOCIATED WITH CORONARY HEART DISEASE SUSCEPTIBILITY
Breslow, J. L. (2000) · Annual Review of Genetics · doi:10.1146/annurev.genet.34.1.233 · Cited by 128
Self-citationTietge, U. J. F., Maugeais, C., Lund‐Katz, S., Grass, D., deBeer, F. C., & Rader, D. J. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000023228.90866.29 · Cited by 126
Silver, D. L., Jiang, X., & Tall, A. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.7.4140 · Cited by 129
Brinton, E. A. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.3.431 · Cited by 125
Self-citationHoeg, J. M., Vaisman, B. L., Demosky, S. J., Meyn, S. M., Talley, G. D., Hoyt, R. F., Feldman, S. H., Bérard, A. M., Sakai, N., Wood, D. R., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4396 · Cited by 116
Freeman, D. J. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.07.001 · Cited by 114
High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences
Francis, G. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00181-x · Cited by 114
Silver, D. L., Wang, N., & Tall, A. R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8087 · Cited by 112
Hepatic lipase and HDL metabolism
Thuren, T. Y. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200006000-00008 · Cited by 111
Qin, S., Kawano, K., Bruce, C., Lin, M., Bisgaier, C. L., Tall, A. R., & Jiang, X. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32061-7 · Cited by 110
Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women
Asztalos, B. F., Swarbrick, M. M., Schaefer, E. J., Dallal, G. E., Horvath, K. V., Ai, M., Stanhope, K. L., Austrheim-Smith, I. T., Wolfe, B. M., Ali, M., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.p900015 · Cited by 108
Watts, G. F., & Playford, D. A. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00170-1 · Cited by 108
Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-I
Blatter, M.-C., Moren, X., & James, R. W. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500281-jlr200 · Cited by 107
Adenovirus-mediated Rescue of Lipoprotein Lipase-deficient Mice
Bogner‐Strauß, J. G., Frank, S., Kratky, D., Hämmerle, G., Hrzenjak, A., Knipping, G., von Eckardstein, A., Kostner, G. M., & Zechner, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104430200 · Cited by 104
Magkos, F., Mohammed, B. S., & Mittendorfer, B. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.164 · Cited by 102
Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women
Asztalos, B. F., Swarbrick, M. M., Schaefer, E. J., Dallal, G. E., Horvath, K. V., Ai, M., Stanhope, K. L., Austrheim-Smith, I. T., Wolfe, B. M., Ali, M. R., et al. (2009) · Journal of Lipid Research · doi:10.1194/jlr.p900015-jlr200 · Cited by 102
Plasma HDL Cholesterol, Triglycerides, and Adiposity
Mahaney, M. C., Blangero, J., Comuzzie, A. G., VandeBerg, J. L., Stern, M. P., & MacCluer, J. W. (1995) · Circulation · doi:10.1161/01.cir.92.11.3240 · Cited by 103
The mechanism of HDL lowering in hypertriglyceridemic, insulin-resistant states
Rashid, S., Uffelman, K. D., & Lewis, G. F. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00191-x · Cited by 101
Influence of dietary carbohydrate and fat on LDL and HDL particle distributions
Siri, P. W., & Krauss, R. M. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0062-9 · Cited by 98
Chan, D. C., Watts, G. F., Nguyen, M. N., & Barrett, P. H. R. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.1.37 · Cited by 96
Lipolytically Modified Triglyceride-Enriched HDLs Are Rapidly Cleared From the Circulation
Rashid, S., Barrett, P. H. R., Uffelman, K. D., Watanabe, T., Adeli, K., & Lewis, G. F. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0302.105374 · Cited by 96
Associations of indices of adiposity with atherogenic lipoprotein subfractions
Sattar, N. A., Tan, C., Han, T. S., Forster, L. F., Lean, M., Shepherd, J., & Packard, C. J. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800604 · Cited by 95
Freeman, Caslake, Griffin, Hinnie, Tan, �., Watson, Packard, & Shepherd (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.00328.x · Cited by 89
Changes of lipolytic enzymes cluster with insulin resistance syndrome
Knudsen, P., Eriksson, J., Lahdenper, S., Kahri, J., Groop, L., Taskinen, M., & The Botnia Study Group (1995) · Diabetologia · doi:10.1007/bf00400640 · Cited by 87
Tan, K. C. B., Shiu, S. W. M., & Kung, A. W. C. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.4938 · Cited by 85
Beard, C. M., Barnard, R. J., Robbins, D. C., Ordovás, J. M., & Schaefer, E. J. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.2.201 · Cited by 82
Levak‐Frank, S., Weinstock, P. H., Hayek, T., Verdery, R. B., Hofmann, W. E., Ramakrishnan, R., Sattler, W., Breslow, J. L., & Zechner, R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.17182 · Cited by 81
Self-citationSmall, Dense Lipoprotein Particles and Reduced Paraoxonase-1 in Patients with the Metabolic Syndrome
Blatter, M.-C., Kalix, B., Morabia, A., & James, R. W. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1295 · Cited by 79
Determinants of plasma HDL concentrations and reverse cholesterol transport
Lewis, G. F. (2006) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000231405.76930.a0 · Cited by 77
Brousseau, M. E., Eberhart, G. P., Dupuis, J., Asztalos, B. F., Goldkamp, A. L., Schaefer, E. J., & Freeman, M. W. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32019-8 · Cited by 77
Foxa2 Activity Increases Plasma High Density Lipoprotein Levels by Regulating Apolipoprotein M
Wolfrum, C., Howell, J. J., Ndungo, E., & Stoffel, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801930200 · Cited by 74
Mendivil, C. O., Furtado, J. D., Morton, A. M., Wang, L., & Sacks, F. M. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306138 · Cited by 76
Asztalos, B. F., Collins, D., Horvath, K. V., Bloomfield, H. E., Robins, S. J., & Schaefer, E. J. (2008) · Metabolism · doi:10.1016/j.metabol.2007.08.009 · Cited by 71
Impaired Serum Lipids and Lipoproteins in Fetal Macrosomia Related to Maternal Obesity
Merzouk, H., Bouchenak, M., Loukidi, B., Prost, J., & Belleville, J. (1999) · Neonatology · doi:10.1159/000014190 · Cited by 74
Arginine-directed glycation and decreased HDL plasma concentration and functionality
Godfrey, L., Yamada-Fowler, N., Smith, J., Thornalley, P. J., & Rabbani, N. (2014) · Nutrition and Diabetes · doi:10.1038/nutd.2014.31 · Cited by 74
Determinants of Plasma HDL-Cholesterol in Hypertriglyceridemic Patients
Tatò, F., Vega, G. L., & Grundy, S. M. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.1.56 · Cited by 72
Chan, D. C., & Watts, G. F. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.502529 · Cited by 69
HDL-replacement therapy: mechanism of action, types of agents and potential clinical indications
Remaley, A. T., Amar, M. J., & Sviridov, D. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.9.1203 · Cited by 69
HDL abnormalities in familial hypercholesterolemia: Focus on biological functions
Ganjali, S., Momtazi‐Borojeni, A. A., Banach, M., Kovanen, P. T., Stein, E. A., & Sahebkar, A. (2017) · Progress in Lipid Research · doi:10.1016/j.plipres.2017.05.001 · Cited by 68
Yan, D., Navab, M., Bruce, C., Fogelman, A. M., & Jiang, X. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400053-jlr200 · Cited by 67
Tan, Shiu, Pang, & Kung (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00372.x · Cited by 65
Hypolipidemic effect of NK-104, a potent HMG-CoA reductase inhibitor, in guinea pigs
Suzuki, H., Aoki, T., Tamaki, T., Sato, F., Kitahara, M., & Saitō, Y. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00146-x · Cited by 65
HDL particle size: a marker of the gender difference in the metabolic risk profile.
Pascot, A., Lemieux, I., Bergeron, J., Tremblay, A., Nadeau, A., Prud'homme, D., Couillard, C., Lamarche, B., & Despres, J. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00579-2 · Cited by 65
Insulin Resistance and Human Disease: A Short History
Reaven, G. M. (1998) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp.1998.9.2-4.387 · Cited by 65
Simonsen, J. B. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.05.009 · Cited by 64
Azrolan, N., Odaka, H., Breslow, J. L., & Fisher, E. A. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.19833 · Cited by 63
Self-citationHager, L., Li, L., Pun, H., Liu, L., Hossain, M. A., Maguire, G. F., Naples, M., Baker, C., Magomedova, L., Tam, J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.340919 · Cited by 63
Rodríguez‐Carrio, J., Alpéri, M., López, P., López‐Mejías, R., Alonso-Castro, S., Abal, F., Ballina‐García, F. J., González-Gay, M. Á., & Suárez, A. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.05.009 · Cited by 60
Familial HDL Deficiency Characterized by Hypercatabolism of Mature ApoA-I but Not ProApoA-I
Batal, R., Tremblay, M., Krimbou, L., Mamer, O., Davignon, J., Genest, J. J., & Cohn, J. S. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.4.655 · Cited by 61
Silva, E. R. D. O. E., Kong, M., Han, Z., Starr, C. J., Kass, E. M., Juo, S. H., Foster, D., Dansky, H. M., Merkel, M., Cundey, K., et al. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33483-0 · Cited by 61
Self-citationWeng, W., Brandenburg, N. A., Zhong, S., Halkias, J., Wu, L., Jiang, X., Tall, A. R., & Breslow, J. L. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33510-0 · Cited by 61
Self-citationType 2 diabetes affects hippocampus volume differentially in men and women
Hempel, R., Onopa, R., & Convit, A. J. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1230 · Cited by 60
Haas, M. J., & Mooradian, A. D. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1057 · Cited by 60
Al-Shoumer, K. A. S., Cox, K. H., Hughes, C. L., Richmond, W., & Johnston, D. G. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4129 · Cited by 60
Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjects
Catalano, G., Duchêne, E., Julia, Z., Goff, W. L., Bruckert, É., Chapman, M. J., & Guérin, M. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700510-jlr200 · Cited by 60
Tan, K. C. B., Shiu, S. W. M., Pang, R. W. C., & Kung, A. W. C. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.3721211.x · Cited by 60
Mazer, N. A., Giulianini, F., Paynter, N. P., Jordan, P., & Mora, S. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.196949 · Cited by 59
Duvillard, L., Pont, F., Florentin, E., Gambert, P., & Vergès, B. L. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00473-6 · Cited by 59
Murdoch, S. J., & Breckenridge, W. C. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05606-8 · Cited by 58
Genetic control of HDL levels and composition in an interspecific mouse cross (CAST/Ei × C57BL/6J)
Mehrabian, M., Castellani, L. W., Wen, P.-Z., Wong, J., Rithaporn, T., Hama, S. Y., Hough, G. P., Johnson, D., Albers, J. J., Mottino, G. A., et al. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32354-3 · Cited by 58
Tailleux, A., Bouly, M., Luc, G., Castro, G. R., Caillaud, J., Hennuyer, N., Poulain, P., Fruchart, J., Duverger, N., & Fiévet, C. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.11.2453 · Cited by 58
Differential response to low-fat diet between low and normal HDL-cholesterol subjects
Asztalos, B. F., LeFevre, M. L., Wong, L., Foster, T. A., Tulley, R. T., WINDHAUSER, M. M., Zhang, W., & Roheim, P. S. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34470-9 · Cited by 57
Metadata
- Authors
- Brinton, E. A., Eisenberg, S., & Breslow, J. L.
- Affiliations
- Rockefeller University (US)
- Venue
- Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
- Published
- 1994-05
- Volume
- 14
- Issue
- 5
- Pages
- 707-720
- ISSN
- 1049-8834 (ISSN-L)
- OpenAlex
- W2155588817
- Cited by
- 265
- References
- 36
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 2 · 2022: 2 · 2020: 2 · 2019: 3 · 2018: 3 · 2017: 6 · 2016: 7 · 2015: 6 · 2014: 5 · 2013: 9 · 2012: 3
- FWCI
- 16.95
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Arteriosclerosis and Thrombosis A Journal of Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pew Charitable Trusts
- Memorial Sloan-Kettering Cancer Center
- National Institutes of Health (5r01hl033714-17, 5r37hl036461-09)
- National Heart, Lung, and Blood Institute (HL 33714, R01HL032435, HL-36461, HL32435)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- HDL cholesterol, apolipoprotein A-I, apolipoprotein A-II, fractional catabolic rate, HDL particle size, sex differences, hepatic lipase, lipoprotein lipase, triglycerides, insulin, body fat distribution, atherosclerosis risk
- MeSH terms
- Adipose Tissue, Adult, Aged, Female, Humans, Insulin, Lipase, Lipoprotein Lipase, Lipoproteins, HDL, Cholesterol, HDL, Liver, Male, Middle Aged, Particle Size, Regression Analysis, Sex Factors, Triglycerides, Apolipoprotein A-I, Apolipoprotein A-II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review